Complete response to weekly carboplatin-docetaxel chemotherapy in a 91-year-old woman with anaplastic thyroid cancer

Am J Otolaryngol. 2015 Mar-Apr;36(2):268-72. doi: 10.1016/j.amjoto.2014.03.006. Epub 2014 Mar 27.

Abstract

Anaplastic thyroid cancer (ATC) is an unusual tumor with the worst prognosis among thyroid malignancies. Treatment of the patients diagnosed with ATC is not standardized and the feasible options include surgery, radiotherapy and chemotherapy. ATC cannot be regarded as a very chemo-sensitive tumor. Herein, we reported a case of a 91-year-old woman with complete response after induction chemotherapy (weekly carboplatin and docetaxel) that underwent subsequent radiotherapy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Biopsy, Fine-Needle
  • Carboplatin / administration & dosage
  • Docetaxel
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Positron-Emission Tomography / methods
  • Radiotherapy, Adjuvant
  • Rare Diseases
  • Remission Induction
  • Taxoids / administration & dosage
  • Thyroid Carcinoma, Anaplastic / diagnostic imaging
  • Thyroid Carcinoma, Anaplastic / drug therapy*
  • Thyroid Carcinoma, Anaplastic / pathology*
  • Thyroid Carcinoma, Anaplastic / radiotherapy
  • Thyroid Neoplasms / diagnostic imaging
  • Thyroid Neoplasms / drug therapy*
  • Thyroid Neoplasms / pathology*
  • Thyroid Neoplasms / radiotherapy
  • Treatment Outcome

Substances

  • Taxoids
  • Docetaxel
  • Carboplatin